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Available online 20 May 2016Objective: Acute ST-elevation myocardial infarcion (STEMI) due to left main coronary artery (LMCA) disease has
highmortality rate. Advancements in stent technology have shown promising results in patientswith unprotect-
ed left main coronary artery (ULMCA) disease. SYNTAX score (SxS) is recommended to determine appropriate
patients for revavascularization with PCI. However, predictive value of SxS in patients with STEMI who
underwent primary PCI due to ULMCA disease has not fully been evaluated.
Methods and Results: 53 patients with STEMI who underwent emergent PCI to a culprit LMCA lesion were en-
rolled in this study. Patients were divided into three groups on the basis of their SxS; low (≤22; n = 14), inter-
mediate ( 23–32; n = 14) and high (≥33; n = 25). During a follow-up of 3 years, SxS exhibited 62.2%
sensitivity and 62.5% speciﬁcity for predictiıng development of MACE at a cut off value 28.25 (AUC: 0.731, P =
0.008), 70% sensitivity and 66.7% speciﬁcity for predicting mortality at a cut off value 31.25 (AUC:0.675, P =
0.034). At 3-year follow-up, the incidences of mortality, major adverse cardiac events (MACE) and targel vessel
revascularization (TVR) were signiﬁcantly higher in patients with high SxS group than in the intermediate and
low SxS groups. In Kaplan–Meier survival analysis, survival rates of the low, intermediate, and high SxS groups
were 91.7%, 78.6%, and 64.7%, respectively.
Conclusions: Patients with acute STEMIwhowere treatedwith emergency PCI to a culprit ULMCA lesion, SxS is an
important aid to deciding the appropriate revascularization strategy, can be derived quickly and repeatable.
© 2016 The Society of Cardiovascular Academy. Production and hosting by Elsevier B.V. All rights reserved. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Unprotected left main coronary artery (ULMCA) disease occurs in 5%
of patients undergoing coronary angiograpy and is a class I indication
for coronary artery bypass graft (CABG) surgery. Acute myocardial
infarction (AMI) due to LMCA occlusion has signiﬁcantly higher rates
of mortality than non-culprit LMCA lesion (16.0% vs. 8.9%).1 In long-
term follow-up, patients with LMCA disease have higher rates of
cardiogenic shock, target lesion revascularization (TLR) and mortality.2
Recent studies have demonstrated that percutaneous coronary inter-
vention (PCI) of the LMCA disease has acceptable in-hospital and
long-term mortality rates. The SYNTAX score (SxS) is an angiographiczettin Aksular cad, Oyak sitesi,
devsi2010@gmail.com,
mail.com (B. Bağırtan),
diovascular Academy.
y. Production and hosting by Elsevscoring tool for grading the complexity of the coronary lesion. It can
be used to help select optimal revascularization strategy in patients
with coronary artery disease.3,4 SxS is an independent predictor of
mortality and TVR after PCI.5,6 Few studies have evaluated the role of
SxS in patients with acute STEMI undergoing primary PCI due to
ULMCA disease. The aim of this study was to assess the prognostic
value of SxS in predicting in-hospital and long term clinical outcomes
among patients who underwent primary PCI for ULMCA lesion.
Methods
Our single-center, retrospective study included 53 patients with
AMI treated with emergency PCI to a culprit ULMCA lesion in our
catheterization laboratory betweenMay 2009 andMarch 2013. Clinical,
biochemical, radiological and social data were extracted from the
national health data system, telephone contact and outpatient
examinations. Patients with protected LMCA disease, renal dysfunction,
chronic anemia, instent thrombosis and who underwent emergency
CABG surgery were excluded from the study.ier B.V. All rights reserved. This is an open access article under the CC BY-NC-ND license
99A. Yıldız et al. / International Journal of the Cardiovascular Academy 2 (2016) 98–102SxS was calculated by summing the total points assigned to each
individual lesion identiﬁed in the coronary arterywith N50% luminal ob-
struction in vessels N1.5 mm in diameter.5 For the calculation, the soft
ware at web site (http://www.syntaxscore.com) was used. On the basis
of their SxS, patients were divided into three groups; low (SxS ≤22;
n= 14), intermediate (SxS 23–32; n= 14) and high (SxS ≥33; n= 25).
Angiographic data of the patients were analyzed by 2 interventional
cardiologists blinded to the clinical characteristics. In the case of
disagreement, a third observer was consulted and a ﬁnal decision was
reached by consensus. Patients received 300mg of aspirin and a loading
dose of (300 to 600 mg) clopidogrel and intravenous (IV) standard
heparin 100 U/kg (maximal dose 10.000 U, 60 U/kg in patients who
were treated with glycoprotein IIb/IIIa inhibitors) before the procedure.
All primary PCI procedures were performed by femoral approach. The
decision on direct or conventional stenting was made by the operator.
The LMCA lesion was considered unprotected if there was no patent
bypass graft to the left anterior descending (LAD) coronary artery or
left circumﬂex coronary artery (LCX). Acute myocardial infarction
(MI) was deﬁned as the presence of typical ongoing ischemic chest
pain lasting for more than 30 min and ST-segment elevation ≥1 mm
in 2 contiguous leads or a new left bundle branch block on the initial
electrocardiogram. Reinfarction was deﬁned as a recurrent typical
chest pain with new electrocardiogram changes and a further increase
in enzyme levels (twice the upper limit of normal reference range or
any rise by 50% of the lowest recovery enzyme level). Target Lesion
Revascularization (TLR) was deﬁned to be any repeat revascularization
with PCI or CABGwithin the stent, orwithin the 5-mmborders proximal
or distal to the stent. Revascularization was considered as successful
treatment of a new lesion in the epicardial vessel. All deaths, including
cardiac deaths, were assessed and ascertained by national databases.
Major adverse cardiovascular events (MACE) were deﬁned as all-cause
mortality, new myocardial infarction and repeat revascularization.
Statistical analysis
Continuous variables were expressed as the mean + standard devi-
ation and categorical variables were expressed as number (percentage).
Group means for continuous variables were compared through 1-wayTable 1
Patients' clinical characteristics and medications.
Low SxS
Male gender, n (%) 10 (23.3)
Mean age (years) 62.86 ± 16.3
LVEF (%) 56.2 ± 9.8
Current smoker, n (%) 7 (50)
Family history of CAD, n (%) 5 (35.7)
DM, n (%) 4 (28.6)
HT, n (%) 10 (71.4)
HL, n (%) 10 (71.4)
In-hospital medical treatment, n (%)
ACE-I/ARB 10 (71.4)
BB 11(78.5)
Glycoprotein IIb/IIIa inhibitors 3 (21.4)
Statins 8 (57.1)
Calcium channel blocker 4 (28.5)
IV diuretic 3 (21.4)
Inotropic drugs 3 (21.4)
Clinic
Killip class ≥2 3 (21.4)
Cardiogenic shock 1 (7.1)
Length of hospital stay, (day) 4.29 ± 1.13
Follow-up period, (day) 923.1 ± 325.3
IABP 2 (14.3)
Temporary pacemaker 2 (14.3)
SxS 18.42 ± 3.2
ACE-I; angiotensin converting enzyme inhibitor, ARB; angiotensin receptor blocker, BB; beta bl
ejection fraction, and SxS; SYNTAX score.analysis of variance. Likewise, categorical variables were compared by
using chi-square test. The Cox proportional hazard model was applied
to relate the SX score and long term mortality, reinfarction, revascular-
ization, and overall major adverse cardiac event (MACE). Multivariate
analysis was applied separately for all outcomes and overall MACE.
The relationship between the SX score and the incidence of MACE was
evaluated. Event free survival curves were generated by the Kaplan–
Meier method and differences in survival were compared by using log
rank test. The receiver-operating characteristic (ROC) curvewasutilized
to determine the cut-off value of SX score in order to predict 3 year
clinical outcomes. A p value less than 0.05 was considered statistically
signiﬁcant. Statistical analyses were conducted using SPSS 22 for
Windows (SPSS Inc., Chicago, Illinois).
Results
Fifty three acute STEMI patients who underwent primary PCI for
ULMCA disease were enrolled in the study. Baseline characteristics of
the patients are shown in Table 1. Mean follow-up period was 28.1 ±
15.5 months (range, 0.17–61.5) and average age of the patients was
66.5 ± 11.8 (range, 34–87) years. Among the 53 patients 43 (81.1%)
of them were male and the remaining (18.9%) were female. Increasing
age was associated with higher SxS values, but this difference was not
statistically signiﬁcant. There was no difference between groups with
respect to smoking status and family history of cardiovascular disease.
Frequency of diabetes mellitus, hypertension, hyperlipidemia, conges-
tive heart failure and cardiogenic shock was signiﬁcantly higher in the
high SxS group compared to low/intermediate SxS groups. Patients
with high SxS were treated more often with diuretics, inotropic agents
and glycoprotein IIb/IIIa inhibitors, intra-aortic balloon pump support
during hospitalization. Three patients required temporary pacing due
to third degree atrioventricular block. Patients in SxS high group had
higher length of hospital stay.
Angiographicﬁndings of patients are shown in Table 2. Patientswere
treated with BMS only, DES only and hybrid stenting (DES + BMS).
Stent type and diameter, balloon length and diameter, distal, ostial/
body LMCA disease and pre-dilatation and post-dilatation rates were
not signiﬁcantly different between the three groups. MultivesselIntermediate SxS High SxS p
14 (32.6) 19 (44.1) 0.52
65.86 ± 8.2 69.04 ± 10.3 0.29
55.1 ± 7.3 41.8 ± 7.6 b0.001
8 (57.1) 15 (60) 0.83
4 (28.6) 10 (40) 0.77
5 (31.3) 18 (78.3) 0.002
10 (62.5) 22 (95.7) 0.03
7 (48.7) 20 (87) 0.015
9 (64.2) 14 (56) 0.62
12 (85.7) 15 (60) 0.19
4 (28.5) 15 (60) 0.03
7 (50) 13 (52) 0.92
5 (35.7) 4(16) 0.36
4 (28.5) 16 (64) 0.02
2 (14.2) 13 (52) 0.03
0.002
3 (21.4) 14 (56) 0.035
0 (0.0) 8 (32) 0.02
4.36 ± 1.08 6.08 ± 2.9 0.03
810.2 ± 305.7 886.5 ± 606.1 0.65
0 (0.0) 8 (32) 0.04
0 (0.0) 1 (0.4) 0.24
26.6 ± 2.3 36.38 ± 4.1 b0.001
ocker, CAD; coronary artery disease, IABP; intraaortic balloon pump, LVEF; left ventricular
Fig. 1. Cutoff value of SxS for predicting the development of MACE.
Table 2
Angiographic ﬁndings of the patients.
Low SxS Intermediate SxS High SxS p
Lesion location, n (%) 0.73
Ostium 4 (28.6) 4 (25) 9 (39.1)
Shaft 4 (28.6) 3 (18.8) 2 (8.7)
Distal 6 (42.9) 9 (56.3) 12 (52.2)
Number of diseased
vessel, n (%)
0.02
LMCA isolated 4 (28.6) 1 (7.1) 4 (16)
LMCA+ 1 vessel 10 (71.4) 9 (64.3) 12 (48)
LMCA+ 2 vessel 0 (0.0) 2(14.3) 9 (36)
LMCA+ 3 vessel 0 (0.0) 0 (0.0) 3 (12)
Predilatation 9 (64.3) 11 (68.8) 10 (43.5) 0.23
Postdilatation 4 (28.6) 5 (33.3) 8 (34.8) 0.92
Types of stent 0.49
BMS 5 (35.7) 6 (37.5) 9 (39.1)
DES 7 (50) 4 (25) 5 (21.7)
Hybrid 1 (7.1) 5 (31.3) 8 (34.8)
Stent length (mm) 20.6 ± 5.9 23.3 ± 7.5 18.1 ± 6.0 0.07
Stent diameter (mm) 3.01 ± 0.48 3.38 ± 0.71 3.02 ± 0.49 0.13
Number of stent used 2.14 ± 1.0 2.71 ± 1.4 2.17 ± 1.1 0.33
Balloon length (mm) 16.25 ± 2.3 14.8 ± 3.1 15.46 ± 3.3 0.61
Balloon diameter (mm) 3.17 ± 0.9 3.02 ± 0.9 3.12 ± 0.8 0.92
BMS; bare metal stent, DES; drug eluting stent, and LMCA; left main coronary artery.
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group than those of in the low/intermediate SxS groups. An average of
2.3 ± 1.1 (min: 1; max: 6) stents were implanted per patient.
There was no difference in in-hospital reinfarction, TLR, and MACE
rates in three groups, while patients with high SxS showed higher
rates of mortality as compared to low/intermediate SxS patients.
During long term follow-up, 51.2% of patients with documented
myocardial ischemia underwent diagnostic coronary angiograpy, of
these 48.7% underwent PCI. There was no difference inMI rate between
the three groups while ischemia-driven TLRwas requiredmore often in
patients with high SX scores. Total mortality and total MACE rates were
signiﬁcantly higher in the SX high group compared with the aggregate
Sx lowand Sx intermediate group. In-hospitalmortality and 3-yearmor-
tality rates of aggregate Sx low and Sx intermediate group and SX-x high
group were 7.1% and 21.4% vs 40% and 56% respectively. In-hospital
complications and 3-year follow-up results are shown in Table 3.
Figs. 1 and 2 show the cutoff value of SxS to predict the development
of MACE and mortality. ROC curve analysis showed that the SxS
exhibited 62.2% sensitivity and 62.5% speciﬁcity for predicting the
development of MACE within 3-years after PCI at a cutoff value of
28.25. (AUC: 0.731 p= .008). SxS predicted mortality with a sensitivity
of 70% and a speciﬁcity of 76% at a cutoff value of 31.25 (AUC: 0.675, p=
0.034). Kaplan–Meier estimated long-term survival rateswere similar inTable 3
In-hospital complications and 3-year follow-up results of the patients.
Low SxS Intermediate SxS High SxS p
In-hospital
Death, n (%) 2 (14.3) 0 (0.0) 10 (40) 0.01
MI, n (%) 1 (7.1) 2 (14.3) 3 (12) 0.83
TLR, n (%) 1 (7.1) 2 (14.3) 3 (12) 0.83
PTCA 1 (7.1) 2 (14.3) 3 (12)
MACE 4 (26.8) 2 (14.3) 10 (40) 0.24
Long-term outcomes
Cardiac deaths, n (%) 1(7.1) 3 (21.4) 4 (16) 0.01
Myocardial infarction, n (%) 2 (14.3) 4 (28.6) 5 (20) 0.73
TLR, n (%) 4 (28.6) 5 (35.7) 11 (44) 0.02
PTCA 2 (14.2) 2 (14.2) 10 (40)
CABG 2 (14.3) 3 (21.4) 1 (4)
MACE, n (%) 6 (42.9) 9 (64.3) 11 (44) b0.001
Total death, n (%) 3 (21.4) 3 (21.4) 14 (56) 0.03
Total TLR, n (%) 4 (28.6) 7 (50) 14 (56) 0.25
Total MACE, n (%) 6 (42.9) 10 (71.4) 21 (84) 0.04the three groups (see Fig. 3). Three-year survival rateswere 91.7%, 78.6%
and 64.7% for SYNTAX low, intermediate, and high groups, respectively.
Discussion
Our results showed that SxS was a useful tool for prediction of in-
hospital and long-term outcomes in STEMI patients who were treated
with emergency PCI to a culprit ULMCA lesion. The optimal cutoff values
for 3-year mortality and MACE were 31.25 and 28.25, respectively. Our
results support the hypothesis that high SxS indicates more complex
coronary artery disease, worse clinical outcomes (worse Killip class,
cardiogenic shock, hemodynamically unstable arrhythmias) andFig. 2. Cutoff value of SxS for predicting the development of mortality.
Fig. 3. Kaplan–Meier estimated long-term survival rates in the three groups.
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advanced age). Length of hospital stay, use of intravenous diuretics
and positive inotropes, in-hospital MACE and mortality increase in
parallel with the SxS. In our previous study,6 we showed that the SxS
was an independent predictor of both in-hospital and long-term
mortality in patients with acute STEMI who underwent primary PCI.
Nozue et al. reported that score 26 was the optimal cutoff value for
predicting one-year MACE in patients who underwent elective PCI for
ULMCA disease.7 Another study showed that a score of 28was the opti-
mal cutoff value to distinguish patients at low and high risk of one-year
MACE.8 Our results are in agreement with previous studies. SxS is an
easily applicable angiographic scoring tool for grading the complexity
of coronary artery disease. It assists in patient selection for interventional
or surgical revascularization.
AcuteMI associatedwith ULMCAocclusion is a clinically catastrophic
event. These critically ill patients frequently present with cardiogenic
shock or cardiac arrest. Patients undergoing primary PCI because of
ULMCA culprit lesion and presenting with cardiogenic shock have high
in-hospitalmortality.9 The average estimated 30-day all-causemortality
was 15% and 55% in patients presenting without and with cardiogenic
shock, respectively.10 Complication rates are twice to four times higher
in patients who undergo primary PCI in acute MI than elective
PCI.11–14 LVEF, previous MI, door-to-balloon time, anemia, chronic
renal failure and diabetes mellitus are independent predictors of
mortality. TIMI and GRACE risk scores are used for risk stratiﬁcation
and prognostic evaluation.
In addition to several clinical risk scores, angiographic characteristics
are used to predict both in-hospital and long-term prognosis. SxS has
been developed aiming to grade the coronary lesions with respect to
their functional impact, location, and complexity.
Consensus treatment guidelines continue to recommend CABG as
the “gold standard” for revascularization of ULMCA lesions but note
that PCI is feasible and may be a promising strategy in selected
patients.15–17 Patients with ostial and trunk LMCA lesions treated with
PCI have better outcomes than patients with distal lesions.16,17
Our in-hospital and 3-year follow-up results suggest that PCI is an
acceptable alternative revascularizationmethod to CABGwhen treating
patients with low or intermediate SX scores. Our results are consistent
with recent studies. Recently published EXEL-trial compared the
efﬁcacy and safety of PCI with CABG surgery in patients with ULMCA
disease and low-intermediate anatomical SxS. In this study, although
PCI patients had worse baseline characteristics (older age, male gender,
COPD), 4-year mortality rate was signiﬁcantly lower than that of CABGpatients. The 4-year predicted mortality for PCI patients was 8.5% and
10.5% for CABG patients.18
High SxS is associated with increasing cardiac mortality, MACE
and TVR at 3 years. Patients with high SxS have signiﬁcantly higher
3 year mortality, MACE and TVR rates. Despite improvement in stent
technology and operator experience, LMCA disease is still associated
with high in-hospital and long term mortality rates and there is a
need of development of new agents and clinical techniques to improve
outcomes further.
Limitations
This was a single-center retrospective study, but the patients were
prospectively followed up. In order to prevent bias, in-hospital and
follow-up data were collected by different clinical investigators. Only
51.2% of patients underwent coronary angiography and clinical
SYNTAX score of the patients was not calculated.
Another limitation was that the development of post-PCI contrast
nephropathy was not evaluated.
Conclusion
The SxS has prognostic value in patients with acute STEMI undergo-
ing primary PCI due to ULMCA disease. It may be useful in selecting the
patients for the most appropriate revascularization strategy.
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